Association between DNA Methylation in Whole Blood and Measures of Glucose Metabolism: KORA F4 Study

Epigenetic regulation has been postulated to affect glucose metabolism, insulin sensitivity and the risk of type 2 diabetes. Therefore, we performed an epigenome-wide association study for measures of glucose metabolism in whole blood samples of the population-based Cooperative Health Research in the Region of Augsburg F4 study using the Illumina HumanMethylation 450 BeadChip. We identified a total of 31 CpG sites where methylation level was associated with measures of glucose metabolism after adjustment for age, sex, smoking, and estimated white blood cell proportions and correction for multiple testing using the Benjamini-Hochberg (B-H) method (four for fasting glucose, seven for fasting insulin, 25 for homeostasis model assessment-insulin resistance [HOMA-IR]; B-H-adjusted p-values between 9.2x10-5 and 0.047). In addition, DNA methylation at cg06500161 (annotated to ABCG1) was associated with all the aforementioned phenotypes and 2-hour glucose (B-H-adjusted p-values between 9.2x10-5 and 3.0x10-3). Methylation status of additional three CpG sites showed an association with fasting insulin only after additional adjustment for body mass index (BMI) (B-H-adjusted p-values = 0.047). Overall, effect strengths were reduced by around 30% after additional adjustment for BMI, suggesting that this variable has an influence on the investigated phenotypes. Furthermore, we found significant associations between methylation status of 21 of the aforementioned CpG sites and 2-hour insulin in a subset of samples with seven significant associations persisting after additional adjustment for BMI. In a subset of 533 participants, methylation of the CpG site cg06500161 (ABCG1) was inversely associated with ABCG1 gene expression (B-H-adjusted p-value = 1.5x10-9). Additionally, we observed an enrichment of the top 1,000 CpG sites for diabetes-related canonical pathways using Ingenuity Pathway Analysis. In conclusion, our study indicates that DNA methylation and diabetes-related traits are associated and that these associations are partially BMI-dependent. Furthermore, the interaction of ABCG1 with glucose metabolism is modulated by epigenetic processes.

[1]  Ziwei Wang,et al.  Type 2 diabetes mellitus control and atherosclerosis prevention in a non-obese rat model using duodenal-jejunal bypass , 2014, Experimental and therapeutic medicine.

[2]  Z. Meng,et al.  Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines , 2012, Diabetologia.

[3]  E. Lammert,et al.  Cell–cell interactions in the endocrine pancreas , 2009, Diabetes, obesity & metabolism.

[4]  S. Gogg,et al.  Insulin resistance and impaired adipogenesis , 2015, Trends in Endocrinology & Metabolism.

[5]  Ian M. Morison,et al.  Integrated Genetic and Epigenetic Analysis Identifies Haplotype-Specific Methylation in the FTO Type 2 Diabetes and Obesity Susceptibility Locus , 2010, PloS one.

[6]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[7]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[8]  Wolfgang Rathmann,et al.  Prediabetes: a high-risk state for diabetes development , 2012, The Lancet.

[9]  Andrea Baccarelli,et al.  Epigenetics and environmental chemicals , 2009, Current opinion in pediatrics.

[10]  Karl T Kelsey,et al.  The fate is not always written in the genes: Epigenomics in epidemiologic studies , 2013, Environmental and molecular mutagenesis.

[11]  E. Korkmazer,et al.  Correlation between inflammatory markers and insulin resistance in pregnancy , 2015, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[12]  T. Kadowaki,et al.  The Epigenome and Its Role in Diabetes , 2012, Current Diabetes Reports.

[13]  J. Lv,et al.  Co-culture with fat cells induces cellular insulin resistance in primary hepatocytes. , 2006, Biochemical and biophysical research communications.

[14]  R. Schwenk,et al.  Genetic and epigenetic control of metabolic health. , 2013, Molecular metabolism.

[15]  Devin C. Koestler,et al.  DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.

[16]  R. Holle,et al.  Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: The KORA S4/F4 Study , 2012, Annals of medicine.

[17]  M. Kasuga,et al.  Lack of association of CPT1A polymorphisms or haplotypes on hepatic lipid content or insulin resistance in Japanese individuals with type 2 diabetes mellitus. , 2007, Metabolism: clinical and experimental.

[18]  M. Moreno-Aliaga,et al.  Differential Proinflammatory and Oxidative Stress Response and Vulnerability to Metabolic Syndrome in Habitual High-Fat Young Male Consumers Putatively Predisposed by Their Genetic Background , 2013, International journal of molecular sciences.

[19]  M. Kohno,et al.  Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes. , 2016, American journal of physiology. Endocrinology and metabolism.

[20]  G. Cowin,et al.  Ski Overexpression in Skeletal Muscle Modulates Genetic Programs That Control Susceptibility to Diet‐Induced Obesity and Insulin Signaling , 2012, Obesity.

[21]  Christian Herder,et al.  Genetics of type 2 diabetes: pathophysiologic and clinical relevance , 2011, European journal of clinical investigation.

[22]  J. A. Nogueira-Machado,et al.  The Production of Nitric Oxide, IL-6, and TNF-Alpha in Palmitate-Stimulated PBMNCs Is Enhanced through Hyperglycemia in Diabetes , 2014, Oxidative medicine and cellular longevity.

[23]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[24]  P. Poulsen,et al.  Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance – a population-based twin study , 1999, Diabetologia.

[25]  E. Hardeman,et al.  The Ski proto-oncogene regulates body composition and suppresses lipogenesis , 2010, International Journal of Obesity.

[26]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[27]  A. von Eckardstein,et al.  Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster. , 2000, The Journal of clinical endocrinology and metabolism.

[28]  P. Visscher,et al.  Twin study of genetic and environmental influences on glucose tolerance and indices of insulin sensitivity and secretion , 2003, Diabetologia.

[29]  Michael Stumvoll,et al.  Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.

[30]  R. Weksberg,et al.  Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray , 2013, Epigenetics.

[31]  C. Gieger,et al.  Analyzing Illumina Gene Expression Microarray Data from Different Tissues: Methodological Aspects of Data Analysis in the MetaXpress Consortium , 2012, PloS one.

[32]  B. Eliasson,et al.  Adipocyte Hypertrophy, Inflammation and Fibrosis Characterize Subcutaneous Adipose Tissue of Healthy, Non-Obese Subjects Predisposed to Type 2 Diabetes , 2014, PloS one.

[33]  H. Petry,et al.  Molecular therapy for obesity and diabetes based on a long‐term increase in hepatic fatty‐acid oxidation , 2011, Hepatology.

[34]  L. Bennett,et al.  Epigenetics in humans: an overview , 2010, Current opinion in endocrinology, diabetes, and obesity.

[35]  Thomas Meitinger,et al.  SNP-Based Analysis of Genetic Substructure in the German Population , 2006, Human Heredity.

[36]  R Holle,et al.  KORA - A Research Platform for Population Based Health Research , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[37]  W. Rathmann,et al.  Type 2 diabetes: prevalence and relevance of genetic and acquired factors for its prediction. , 2013, Deutsches Arzteblatt international.

[38]  Martin J Aryee,et al.  Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts , 2009, Nature Genetics.

[39]  Daniel L. McGee,et al.  Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: The Framingham Study. , 1981, American journal of epidemiology.

[40]  Tom R. Gaunt,et al.  Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. , 2015, The lancet. Diabetes & endocrinology.

[41]  Christian Gieger,et al.  Tobacco Smoking Leads to Extensive Genome-Wide Changes in DNA Methylation , 2013, PloS one.

[42]  S. Choudhuri,et al.  Molecular targets of epigenetic regulation and effectors of environmental influences. , 2010, Toxicology and applied pharmacology.

[43]  C. Hedrick,et al.  An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells. , 2010, The Journal of clinical investigation.

[44]  C. Ayers,et al.  Reduced Expression of ATP-Binding Cassette Transporter G1 Increases Cholesterol Accumulation in Macrophages of Patients With Type 2 Diabetes Mellitus , 2008, Circulation.

[45]  Jiarui Wu,et al.  Cyclin Y Is Involved in the Regulation of Adipogenesis and Lipid Production , 2015, PloS one.

[46]  L. Marullo,et al.  Insights into the Genetic Susceptibility to Type 2 Diabetes from Genome-Wide Association Studies of Glycaemic Traits , 2014, Current Diabetes Reports.

[47]  Leif Groop,et al.  Differential gene expression in adipose tissue from obese human subjects during weight loss and weight maintenance. , 2012, The American journal of clinical nutrition.

[48]  Gérard Waeber,et al.  Association between circulating cytokine levels, diabetes and insulin resistance in a population‐based sample (CoLaus study) , 2013, Clinical endocrinology.

[49]  James D. Johnson,et al.  Loss of Both ABCA1 and ABCG1 Results in Increased Disturbances in Islet Sterol Homeostasis, Inflammation, and Impaired β-Cell Function , 2012, Diabetes.

[50]  Ephs and Ephrins Keep Pancreatic β Cells Connected , 2007, Cell.

[51]  K. Feingold,et al.  Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. , 1989, The Journal of clinical investigation.

[52]  Liqi Zhu,et al.  Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells , 2013, PloS one.

[53]  H. Löwel,et al.  High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000 , 2003, Diabetologia.

[54]  Hemant K. Tiwari,et al.  Epigenome-Wide Association Study of Fasting Measures of Glucose, Insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network Study , 2014, Diabetes.

[55]  Mark I. McCarthy,et al.  Type 2 diabetes and obesity: genomics and the clinic , 2011, Human Genetics.

[56]  Yan Zhao,et al.  Maternal Circulating Concentrations of Tumor Necrosis Factor-Alpha, Leptin, and Adiponectin in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis , 2014, TheScientificWorldJournal.

[57]  D. Hernandez,et al.  DNA Methylation of Lipid-Related Genes Affects Blood Lipid Levels , 2015, Circulation. Cardiovascular genetics.

[58]  Jaipaul Singh,et al.  Inflammatory Process in Type 2 Diabetes , 2006 .

[59]  P. Halban,et al.  Novel Mechanistic Link between Focal Adhesion Remodeling and Glucose-stimulated Insulin Secretion* , 2011, The Journal of Biological Chemistry.

[60]  Robin Holliday,et al.  Epigenetics: A Historical Overview , 2006, Epigenetics.

[61]  R. Holle,et al.  Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[62]  Tanya M. Teslovich,et al.  Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility , 2014, Nature Genetics.

[63]  F. Wolf Standards of Medical Care in Diabetes—2014 , 2013, Diabetes Care.

[64]  M. Lorenzo,et al.  c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists. , 2009, The Journal of clinical endocrinology and metabolism.

[65]  W. Rathmann,et al.  Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study. , 2015, European journal of endocrinology.

[66]  L. Cocco,et al.  Nuclear PLCs affect insulin secretion by targeting PPARγ in pancreatic β cells , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  C. Gieger,et al.  Mapping the Genetic Architecture of Gene Regulation in Whole Blood , 2014, PloS one.

[68]  L. Hou,et al.  Environmental chemical exposures and human epigenetics. , 2012, International journal of epidemiology.

[69]  W. Wurst,et al.  EphA-Ephrin-A-Mediated β Cell Communication Regulates Insulin Secretion from Pancreatic Islets , 2007, Cell.

[70]  S. Cohen,et al.  MAPK/ERK Signaling Regulates Insulin Sensitivity to Control Glucose Metabolism in Drosophila , 2011, PLoS genetics.

[71]  J. Schug,et al.  Transcriptomes of the major human pancreatic cell types , 2011, Diabetologia.

[72]  Francesco Marabita,et al.  A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data , 2012, Bioinform..

[73]  P. Poulsen,et al.  Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. , 2005, Diabetes.

[74]  A J Carlson,et al.  Frederick R. Rickles, MD, FACP, Appointed Executive Director of the Federation of American Societies for Experimental Biology , 2004, Journal of Investigative Medicine.

[75]  Yoshikazu Nakamura,et al.  Genetic Defect in Phospholipase Cδ1 Protects Mice From Obesity by Regulating Thermogenesis and Adipogenesis , 2011, Diabetes.

[76]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[77]  A. Tall,et al.  ATP-binding cassette transporters, atherosclerosis, and inflammation. , 2014, Circulation research.

[78]  C. Kahn,et al.  Ephs and ephrins keep pancreatic Beta cells connected. , 2007, Cell.

[79]  C. D. de Souza,et al.  Reversion of Steatosis by SREBP-1c Antisense Oligonucleotide did not Improve Hepatic Insulin Action in Diet-induced Obesity Mice , 2012, Hormone and Metabolic Research.

[80]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[81]  V Jakus,et al.  Impact of glycemic control on advanced glycation and inflammation in overweight and obese patients with type 2 diabetes mellitus. , 2014, Bratislavske lekarske listy.

[82]  J. Zierath,et al.  Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. , 2009, Cell metabolism.

[83]  S. Wild,et al.  Diabetes in Europe: an update. , 2014, Diabetes research and clinical practice.

[84]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[85]  K. Huse,et al.  Allele-Specific, Age-Dependent and BMI-Associated DNA Methylation of Human MCHR1 , 2011, PloS one.

[86]  S. Grant,et al.  Genetic Susceptibility to Type 2 Diabetes and Obesity: Follow-Up of Findings from Genome-Wide Association Studies , 2014, International journal of endocrinology.

[87]  Jaipaul Singh,et al.  Inflammatory process in type 2 diabetes: The role of cytokines. , 2006, Annals of the New York Academy of Sciences.

[88]  A. Feinberg,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[89]  Cloning and functional analysis of goat glucose transporter 4 , 2013, Molecular Biology Reports.

[90]  Mark I. McCarthy,et al.  Mendelian Randomization Studies Do Not Support a Role for Raised Circulating Triglyceride Levels Influencing Type 2 Diabetes, Glucose Levels, or Insulin Resistance , 2011, Diabetes.

[91]  M. Roden,et al.  Heat Shock Protein 60 as a Mediator of Adipose Tissue Inflammation and Insulin Resistance , 2012, Diabetes.

[92]  Dvir Aran,et al.  Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. , 2012, Human molecular genetics.

[93]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[94]  Dong Sun Kim,et al.  Effect of Body Mass Index on Global DNA Methylation in Healthy Korean Women , 2014, Molecules and cells.

[95]  Robert V Farese,et al.  Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. , 2012, Cell metabolism.

[96]  Mingzhi Xu,et al.  Associations of ATP-Binding Cassette Transporter A1 and G1 With Insulin Secretion in Human Insulinomas , 2012, Pancreas.